ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 240529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 240529; 2) Community: the network communities that were significantly associated with the response to NSC 240529; 3) Molecule: the relationships between components within communities and NSC 240529; 4) MDR: the compounds that were significantly associated with the NSC 240529.

NSC Compound Enrichment Correlation
NSC 268993 Deferoxamine hydrochloride 0.0178844438004194 0.39691193
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0178844438004194 -0.1540611
NSC 282159 EN 589 0.0178844438004194 0.39855843
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0178844438004194 0.56733445
NSC 302991 Camptothecin Derivative 0.0178844438004194 0.56699838
NSC 622070 Null 0.0178844438004194 0.20773543
NSC 628560 Null 0.0178844438004194 0.32255521
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.0178844438004194 0.27191936
NSC 633512 Null 0.0178844438004194 0.45386532
NSC 635414 Null 0.0178844438004194 0.21078566
Total:99  Current:42    [First] [Prev] [Next] [Last]